Clinical Trial Update: Asparaginase Encapsulated in Erythrocytes for Patients With ALL and Hypersensitivity to PEG-asparaginase [Phase 2]

View source ↗

Summary

Phase 2 trial of erythrocyte-encapsulated asparaginase for Acute Lymphoblastic Leukemia patients with hypersensitivity to PEG-asparaginase has completed with po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Asparaginase encapsulated in erythrocytes

Snippet

Sponsor: Birgitte Klug Albertsen | Conditions: Acute Lymphoblastic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2024-03-15